OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
Patent Cooperation Treaty
PCT/US2017/065270
Filed on 2017-12-08
PCT/US2017/065270
Filed on 2017-12-08
Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
Switzerland
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15
Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
Ireland
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15
Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
United Kingdom
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15
Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
Germany
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15
Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
France
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15
Genetic control of MRI signal
Patent Cooperation Treaty
PCT/US2024/011377
Filed on 2024-01-12
PCT/US2024/011377
Filed on 2024-01-12
D3 Dopamine Receptor-Selective Negative Allosteric Modulators.
European Patent
22761746.1
Filed on 2024-01-29
22761746.1
Filed on 2024-01-29
D3 Dopamine Receptor-Selective Negative Allosteric Modulators.
US Application 18/294,663
Filed on 2024-02-02
Filed on 2024-02-02
ANGUBINDIN-1 TREATMENT AGAINST MALIGNANT GLIOMA
Patent Cooperation Treaty
PCT/US2023/079547
Filed on 2023-11-13
PCT/US2023/079547
Filed on 2023-11-13